USCareCheck

CMS certification 053300

Valley Children's Hospital

9300 Valley Childrens Place, Madera, CA 93636

Childrens Emergency services

This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.

CMS overall rating Not rated Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.
Would definitely recommend No survey results published
Patient survey rating Not rated HCAHPS patient survey
Compared with the nation Too few cases for CMS to compare

What patients said

Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.

Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.

Not reported for this hospital

CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.

Clinicians registered at this address

583 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 66 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.

Specialty Clinicians
Pediatrics 110
Pharmacist 59
Clinical 51
Speech-Language Pathologist 25
Family 20
Neonatal-Perinatal Medicine 20
Pediatric Emergency Medicine 17
Genetic Counselor, MS 14
Social Worker 14
Anesthesiology 13
Pediatric Gastroenterology 13
Maternal & Fetal Medicine 12

First 12 alphabetically

Money from drug and device companies

Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.

2025 total $171,834 general $30,666 · research $141,168
All years, 2019–2025 $1M 385 reported payments
Studies funded, 2025 15 22 companies paid in total
  • 2019 $170,309
  • 2020 $162,845
  • 2021 $194,707
  • 2022 $130,987
  • 2023 $85,006
  • 2024 $129,849
  • 2025 $171,834

General payments Research payments

What the 2025 general payments were for

Type of payment Amount Payments
Grants $10,500 5
Medical devices and supplies on long-term loan $10,345 3
Education $5,500 3
Space rental and facility fees $3,150 3
Gifts $1,000 1
Debt forgiveness $171 4

Largest paying companies, 2025

Company Amount Payments
Abbvie INC. $65,804 4
Genentech, Inc. $36,153 6
Novartis Pharmaceuticals Corporation $12,786 4
MED-EL Corporation $9,090 1
Abbott Laboratories $8,950 1
SpringWorks Therapeutics, Inc. $7,500 3
Vertex Pharmaceuticals Incorporated $6,500 1
HEMA Biologics, LLC $5,675 1

Largest research studies funded here, 2025

Study Amount
A23-488;Venclexta;Bottle: ABT-199 100mg Yellow Film Coated Tablet 120 Tablets ABBVIE INC. $62,472
Risdiplam post gene therapy study plateau symptoms study 2 Genentech, Inc. $21,000
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT Genentech, Inc. $14,520
A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy Novartis Pharmaceuticals Corporation $11,286
NCT02097420--HALO: A Single Arm Prospective Investigation of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve Abbott Laboratories $8,950
A Non-Interventional Study Evaluating the Impact of TRIKAFTA Initiation on 2- to 5-Year-Olds With Cystic Fibrosis and Their Caregivers in a Real-Worl… VERTEX PHARMACEUTICALS INCORPORATED $6,500
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT HEMA Biologics, LLC · NCT05904210 $5,675
ANBL1531 LORLATINIB ARM A PHASE 3 STUDY OF 131IMETAIODOBENZYLGUANIDINE 131IMIBG OR ALK INHIBITOR THERAPY ADDED TO INTENSIVE THERAPY FOR CHILDREN WIT… PFIZER INC. $4,800

Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.

How to read this page

  • Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
  • “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
  • Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
  • Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
  • These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.

CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error

Common questions about Valley Children's Hospital

Does Valley Children's Hospital have an emergency room?

Yes. CMS lists emergency services at Valley Children's Hospital.

Does Valley Children's Hospital receive money from drug and device companies?

Drug and device makers reported $171,834 in payments to Valley Children's Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.